AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2022
May 18, 2022
34519_dirs_2022-05-18_28524900-e263-434b-8a93-a063d4e8d45f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2022-05-16
Reporting Person: Tomsche David Scott (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-16 | Common Stock, par valude $0.10 per share | D | 200 | $8.35 | Acquired | 85719 | Direct |
| 2022-05-17 | Common Stock, par valude $0.10 per share | D | 3400 | $8.37 | Acquired | 89119 | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23